Concepedia

Hans-Nicolas Macha

HM

Statistics

Publications

1

Citations

97

H-Index

1

Active since

2003

Affiliations

LungenClinic Grosshansdorf(Current)

Hans-Nicolas Macha is an author at LungenClinic Grosshansdorf specializing in topoisomerase inhibitor combinations, chemotherapy-induced pulmonary toxicity, and lung cancer staging.

Publications per year

2003–2003

1

Publications

1

Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer

Martin Reck, Joachim von Pawel, Hans-Nicolas Macha et al. · JNCI Journal of the National Cancer Institute · 2003 · 97 citations

Medicine, Oncology, Pharmacology +14

1–1 of 1